Advagene Biopharma Co., Ltd. (6709.TWO)
TWD 18.0
(-14.29%)
TWD 18.0
(-14.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -80.07 Million TWD | 24.95% |
| 2022 | -106.69 Million TWD | -25.77% |
| 2021 | -84.83 Million TWD | -36.46% |
| 2020 | -62.16 Million TWD | 34.07% |
| 2019 | -94.28 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -15.51 Thousand TWD | 29.61% |
| 2024 Q2 | -15.51 Thousand TWD | -2.99% |
| 2023 FY | - TWD | 24.95% |
| 2023 Q4 | -22.04 Thousand TWD | 0.0% |
| 2023 Q3 | -22.04 Thousand TWD | 2.49% |
| 2023 Q2 | -22.61 Thousand TWD | 0.0% |
| 2023 Q1 | -22.61 Thousand TWD | 25.76% |
| 2022 Q3 | -30.45 Thousand TWD | 0.0% |
| 2022 FY | - TWD | -25.77% |
| 2022 Q4 | -30.45 Thousand TWD | 0.0% |
| 2021 FY | - TWD | -36.46% |
| 2020 FY | - TWD | 34.07% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -73.151% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 120.343% |
| Level Biotechnology Inc. | 98.7 Million TWD | 181.123% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -78.976% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -11.034% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -217.33% |
| GlycoNex Incorporation | -126.82 Million TWD | 36.865% |
| VBI | -6.97 Million TWD | -1048.48% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 44.276% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 467.134% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -351.721% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 22.722% |
| Visgeneer Inc. | 973 Thousand TWD | 8329.394% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 76.414% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 108.55% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 180.203% |
| Neith Corporation | -33.61 Million TWD | -138.239% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 91.921% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -4509.787% |
| Enimmune corporation | -228.96 Million TWD | 65.028% |
| TaiRx, Inc. | -208.64 Million TWD | 61.623% |
| CHO Pharma, Inc. | -277.73 Million TWD | 71.169% |
| EirGenix Inc. | -664.4 Million TWD | 87.948% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 208.346% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 215.806% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 92.526% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 29.206% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 329.841% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -28.442% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -204.456% |
| RBC Bioscience Corporation | 36.54 Million TWD | 319.093% |
| BiOptic Inc. | 65.03 Million TWD | 223.116% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 88.267% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -142.598% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -45.811% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 118.469% |
| NaviFUS Corp. | -55.79 Million TWD | -43.511% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -382.42% |
| Sinew Pharma Inc. | -163.63 Million TWD | 51.066% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -30.198% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 141.617% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 64.676% |
| AP Biosciences Inc | -325.51 Million TWD | 75.401% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 92.335% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -123.378% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 374.878% |
| Intech Biopharm Corporation | -219.58 Million TWD | 63.535% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 88.124% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -78.132% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 50.222% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 112.215% |
| TCI GENE Inc. | 25.98 Million TWD | 408.194% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 27.627% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 71.784% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 45.145% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 678.137% |
| PharmaEngine, Inc. | 347.3 Million TWD | 123.055% |
| Savior Lifetec Corporation | 219.6 Million TWD | 136.462% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 146.491% |
| OBI Pharma, Inc. | -855.08 Million TWD | 90.636% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 13.495% |
| Acepodia, Inc. | -764.51 Million TWD | 89.526% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 82.596% |